Quince Therapeutics, Inc. QNCX
31.73 USD +2.37 (+8.07%)
At closeOct 9, 2026, 4:00 PM EDT
32.00 +0.27 +0.85%
After hours · Oct 9, 4:00 PM ET
29.84 Day range 37.00
0.08 52-week range 37.00
- YTD
- -95.26%
- 1 year
- -91.82%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 9.00 -71.6% downside
Now 31.73
- Target (low)
- 6.00
- Target (mean)
- 9.00
- Target (high)
- 12.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy1
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 2
- 2 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.10 | -0.10 – -0.10 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | -1.17 | -1.17 – -1.17 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Next year | -0.31 | -0.31 – -0.31 | -1.17 | +73.5% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 18, 2024 | Brookline Capital | Initiated | — | Buy |
| Nov 14, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Nov 12, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Nov 7, 2024 | Maxim Group | Initiated | — | Buy |
| Oct 29, 2024 | Rodman & Renshaw | Initiated | — | Buy |
| Oct 22, 2024 | EF Hutton | Initiated | — | Buy |